These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14699405)

  • 1. Human primary immunodeficiency diseases: a perspective.
    Fischer A
    Nat Immunol; 2004 Jan; 5(1):23-30. PubMed ID: 14699405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficiencies with autoimmune consequences.
    Notarangelo LD; Gambineri E; Badolato R
    Adv Immunol; 2006; 89():321-70. PubMed ID: 16682278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies.
    Luo Z; Ronai D; Scharff MD
    J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin class switch recombination deficiencies.
    Kracker S; Gardes P; Mazerolles F; Durandy A
    Clin Immunol; 2010 May; 135(2):193-203. PubMed ID: 20167540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in AID and UNG extend the function of AID.
    Li Z; Woo CJ; Scharff MD
    Nat Immunol; 2003 Oct; 4(10):945-6. PubMed ID: 14515126
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating antibody diversity: taming a mutagen.
    Gearhart PJ; Sen R
    Mol Cell; 2008 Sep; 31(5):615-6. PubMed ID: 18775319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and genetic bases of new primary immunodeficiencies.
    Maródi L; Notarangelo LD
    Nat Rev Immunol; 2007 Nov; 7(11):851-61. PubMed ID: 17960151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunodeficiencies: a field in its infancy.
    Casanova JL; Abel L
    Science; 2007 Aug; 317(5838):617-9. PubMed ID: 17673650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody diversity: one enzyme to rule them all.
    Nussenzweig MC; Alt FW
    Nat Med; 2004 Dec; 10(12):1304-5. PubMed ID: 15580255
    [No Abstract]   [Full Text] [Related]  

  • 16. From infectious diseases to primary immunodeficiencies.
    Bustamante J; Zhang SY; von Bernuth H; Abel L; Casanova JL
    Immunol Allergy Clin North Am; 2008 May; 28(2):235-58, vii. PubMed ID: 18424331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA deamination in immunity.
    Petersen-Mahrt S
    Immunol Rev; 2005 Feb; 203():80-97. PubMed ID: 15661023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.
    Durandy A; Cantaert T; Kracker S; Meffre E
    Autoimmunity; 2013 Mar; 46(2):148-56. PubMed ID: 23215867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.
    Quartier P; Bustamante J; Sanal O; Plebani A; Debré M; Deville A; Litzman J; Levy J; Fermand JP; Lane P; Horneff G; Aksu G; Yalçin I; Davies G; Tezcan I; Ersoy F; Catalan N; Imai K; Fischer A; Durandy A
    Clin Immunol; 2004 Jan; 110(1):22-9. PubMed ID: 14962793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysregulation in primary immunodeficiency disorders.
    Torgerson TR
    Immunol Allergy Clin North Am; 2008 May; 28(2):315-27, viii-ix. PubMed ID: 18424335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.